Drug intelligence / Profile preview

N-(3-Phenyl-2-sulfanylpropanoyl)phenylalanylalanine

Development stage
Unknown
Modality
Peptides, Small Molecules
01

Overview

N-(3‑Phenyl‑2‑sulfanylpropanoyl)phenylalanylalanine is a synthetic dipeptide small molecule, classified as an experimental compound. It consists of a phenyl-substituted sulfhydryl propanoyl group linked to the dipeptide phenylalanylalanine. The compound has not been approved for any medical use and there are no known clinical trials or indications associated with it. Its mechanism of action, pharmacological activity, and therapeutic potential have not been described in the literature or major drug databases[1][3][4]. It is primarily referenced in chemical and structural biology resources.

Other names
(2S)-2-[(2S)-3-phenyl-2-[(2R)-3-phenyl-2-sulfanylpropanamido]propanamido]propanoic acid(2S)-2-((2S)-3-phenyl-2-((2R)-3-phenyl-2-sulfanylpropanamido)propanamido)propanoic acidN-(3-PHENYL–2-SULFANYLPROPANOYL)PHENYLALANYLALANINENalpha-[benzyloxycarbonyl]-L-alanyl-L-alanine (possible synonym from structural analogs)
02

Targets

NEP (Neutral Endopeptidase)

Beyond the preview

Go deeper on N-(3-Phenyl-2-sulfanylpropanoyl)phenylalanylalanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-(3-Phenyl-2-sulfanylpropanoyl)phenylalanylalanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call